| (-)-epigallocatechin 3-gallate | decreases expression | EXP | | 6480464 | epigallocatechin gallate results in decreased expression of CDK4 protein | CTD | PMID:15142168 |
| (S)-nicotine | multiple interactions | EXP | | 6480464 | Bungarotoxins inhibits the reaction [Nicotine results in decreased expression of CDK4 protein]; more ... | CTD | PMID:15231866 |
| (S)-nicotine | decreases expression | ISO | | 6480464 | Nicotine results in decreased expression of CDK4 protein; more ... | CTD | PMID:17135361 |
| (S)-nicotine | decreases expression | ISO | RGD:732062 | 6480464 | Nicotine results in decreased expression of CDK4 mRNA; more ... | CTD | PMID:17135361 |
| (S)-nicotine | decreases expression | EXP | | 6480464 | Nicotine results in decreased expression of CDK4 protein | CTD | PMID:15231866 |
| (S)-nicotine | multiple interactions | EXP | | 6480464 | Nicotine promotes the reaction [CDK4 protein binds to CCND1 protein] | CTD | PMID:18805435 |
| 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | increases expression | ISO | | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in increased expression of CDK4 protein | CTD | PMID:15525693 |
| 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | increases expression | ISO | RGD:732062 | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in increased expression of CDK4 protein | CTD | PMID:15525693 |
| 1,3-dinitrobenzene | increases expression | ISO | RGD:621120 | 6480464 | 3-dinitrobenzene results in increased expression of CDK4 mRNA | CTD | PMID:22841810 |
| 1,3-dinitrobenzene | increases expression | ISO | | 6480464 | 3-dinitrobenzene results in increased expression of CDK4 mRNA | CTD | PMID:22841810 |
| 1,3-thiazolidine-2,4-dione | decreases expression | EXP | | 6480464 | 2,4-thiazolidinedione results in decreased expression of CDK4 protein | CTD | PMID:15916743 |
| 17alpha-ethynylestradiol | decreases expression | ISO | | 6480464 | Ethinyl Estradiol results in decreased expression of CDK4 mRNA | CTD | PMID:16140622 more ... |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:621120 | 6480464 | Ethinyl Estradiol results in decreased expression of CDK4 mRNA | CTD | PMID:12655037 more ... |
| 17alpha-ethynylestradiol | decreases expression | ISO | | 6480464 | Ethinyl Estradiol results in decreased expression of CDK4 mRNA | CTD | PMID:17108234 more ... |
| 17alpha-ethynylestradiol | decreases expression | ISO | | 6480464 | Ethinyl Estradiol results in decreased expression of CDK4 mRNA | CTD | PMID:12655037 more ... |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:621120 | 6480464 | Ethinyl Estradiol results in decreased expression of CDK4 mRNA | CTD | PMID:16140622 more ... |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:621120 | 6480464 | Ethinyl Estradiol results in decreased expression of CDK4 mRNA | CTD | PMID:17108234 more ... |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:621120 | 6480464 | Ethinyl Estradiol results in increased expression of CDK4 mRNA | CTD | PMID:16174780 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:621120 | 6480464 | Ethinyl Estradiol results in decreased expression of CDK4 mRNA | CTD | PMID:17108234 more ... |
| 17alpha-ethynylestradiol | increases expression | ISO | | 6480464 | Ethinyl Estradiol results in increased expression of CDK4 mRNA | CTD | PMID:16174780 |
| 17beta-estradiol | multiple interactions | ISO | | 6480464 | Estradiol inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of CDK4 mRNA]; more ... | CTD | PMID:19874833 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | Estradiol inhibits the reaction [CDK4 protein binds to CDKN1A protein]; more ... | CTD | PMID:9705214 |
| 17beta-estradiol | increases activity | EXP | | 6480464 | Estradiol results in increased activity of CDK4 protein | CTD | PMID:9705214 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | fulvestrant inhibits the reaction [Estradiol results in increased expression of CDK4 protein] | CTD | PMID:19361625 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of CDK4 protein | CTD | PMID:19361625 |
| 17beta-estradiol | multiple interactions | ISO | RGD:732062 | 6480464 | Estradiol inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of CDK4 mRNA]; more ... | CTD | PMID:19874833 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of CDK4 mRNA | CTD | PMID:21826169 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CDK4 mRNA | CTD | PMID:16960034 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:621120 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [CCND2 protein binds to CDK4 protein] | CTD | PMID:12387751 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased activity of CDK4 protein]; more ... | CTD | PMID:9705214 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [AHR protein binds to CDK4 protein]; more ... | CTD | PMID:19917880 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CDK4 mRNA | CTD | PMID:19770486 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene promotes the reaction [CDK4 protein binds to CCND1 protein]]; more ... | CTD | PMID:20637255 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:732062 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene promotes the reaction [CDK4 protein binds to CCND1 protein]]; more ... | CTD | PMID:20637255 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:732062 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CDK4 mRNA | CTD | PMID:19770486 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:621120 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CDK4 mRNA | CTD | PMID:16960034 |
| 2,4-dinitrotoluene | affects expression | ISO | | 6480464 | 2,4-dinitrotoluene affects the expression of CDK4 mRNA | CTD | PMID:21346803 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:621120 | 6480464 | 2,4-dinitrotoluene affects the expression of CDK4 mRNA | CTD | PMID:21346803 |
| 2-acetamidofluorene | increases activity | ISO | | 6480464 | 2-Acetylaminofluorene results in increased activity of CDK4 protein | CTD | PMID:15158336 |
| 2-acetamidofluorene | increases activity | ISO | RGD:621120 | 6480464 | 2-Acetylaminofluorene results in increased activity of CDK4 protein | CTD | PMID:15158336 |
| 2-nitrofluorene | increases expression | ISO | | 6480464 | 2-nitrofluorene results in increased expression of CDK4 mRNA | CTD | PMID:15890375 |
| 2-nitrofluorene | increases expression | ISO | RGD:621120 | 6480464 | 2-nitrofluorene results in increased expression of CDK4 mRNA | CTD | PMID:15890375 |
| 3-nitropropanoic acid | increases expression | ISO | | 6480464 | 3-nitropropionic acid results in increased expression of CDK4 protein | CTD | PMID:21827787 |
| 3-nitropropanoic acid | increases expression | ISO | RGD:621120 | 6480464 | 3-nitropropionic acid results in increased expression of CDK4 protein | CTD | PMID:21827787 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases expression | ISO | | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CDK4 mRNA | CTD | PMID:15890375 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases expression | ISO | RGD:621120 | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CDK4 mRNA | CTD | PMID:15890375 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | multiple interactions | EXP | | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone promotes the reaction [CDK4 protein binds to CCND1 protein] | CTD | PMID:18805435 |
| 5-azacytidine | decreases expression | EXP | | 6480464 | Azacitidine analog results in decreased expression of CDK4 protein | CTD | PMID:18324645 |
| 7,12-dimethyltetraphene | increases expression | ISO | RGD:621120 | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDK4 mRNA | CTD | PMID:12376462 |
| acetaldehyde | increases expression | ISO | RGD:621120 | 6480464 | Acetaldehyde results in increased expression of CDK4 mRNA | CTD | PMID:18234639 PMID:14636436 |
| acetaldehyde | increases expression | ISO | | 6480464 | Acetaldehyde results in increased expression of CDK4 mRNA | CTD | PMID:14636436 PMID:18234639 |
| acetaldehyde | multiple interactions | ISO | RGD:621120 | 6480464 | PD 98059 inhibits the reaction [Acetaldehyde results in increased expression of CDK4 mRNA] | CTD | PMID:18234639 PMID:14636436 |
| acetaldehyde | increases expression | ISO | RGD:621120 | 6480464 | Acetaldehyde results in increased expression of CDK4 mRNA | CTD | PMID:14636436 PMID:18234639 |
| acetaldehyde | multiple interactions | ISO | | 6480464 | PD 98059 inhibits the reaction [Acetaldehyde results in increased expression of CDK4 mRNA] | CTD | PMID:18234639 PMID:14636436 |
| acetaldehyde | multiple interactions | ISO | | 6480464 | PD 98059 inhibits the reaction [Acetaldehyde results in increased expression of CDK4 mRNA] | CTD | PMID:14636436 PMID:18234639 |
| acetaldehyde | increases expression | ISO | | 6480464 | Acetaldehyde results in increased expression of CDK4 mRNA | CTD | PMID:18234639 PMID:14636436 |
| acetaldehyde | multiple interactions | ISO | RGD:621120 | 6480464 | PD 98059 inhibits the reaction [Acetaldehyde results in increased expression of CDK4 mRNA] | CTD | PMID:14636436 PMID:18234639 |
| acetylsalicylic acid | decreases expression | EXP | | 6480464 | Aspirin results in decreased expression of CDK4 mRNA | CTD | PMID:20457246 |
| acrylamide | decreases expression | ISO | RGD:732062 | 6480464 | Acrylamide analog results in decreased expression of CDK4 protein | CTD | PMID:17317719 |
| acrylamide | decreases expression | ISO | | 6480464 | Acrylamide analog results in decreased expression of CDK4 protein | CTD | PMID:17317719 |
| aflatoxin B1 | increases expression | ISO | | 6480464 | Aflatoxin B1 results in increased expression of CDK4 mRNA | CTD | PMID:15890375 |
| aflatoxin B1 | increases expression | ISO | RGD:621120 | 6480464 | Aflatoxin B1 results in increased expression of CDK4 mRNA | CTD | PMID:15890375 |
| albuterol | increases expression | EXP | | 6480464 | Albuterol results in increased expression of CDK4 protein | CTD | PMID:18362475 |
| all-trans-retinoic acid | increases activity | EXP | | 6480464 | Tretinoin results in increased activity of CDK4 protein | CTD | PMID:15695403 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:621120 | 6480464 | Tretinoin inhibits the reaction [sodium arsenite results in decreased expression of CDK4 mRNA] | CTD | PMID:21964460 |
| all-trans-retinoic acid | multiple interactions | ISO | | 6480464 | Tretinoin inhibits the reaction [sodium arsenite results in decreased expression of CDK4 mRNA] | CTD | PMID:21964460 |
| all-trans-retinoic acid | decreases expression | ISO | | 6480464 | Tretinoin results in decreased expression of CDK4 protein | CTD | PMID:11675954 |
| all-trans-retinoic acid | multiple interactions | ISO | | 6480464 | Tretinoin inhibits the reaction [FGF2 protein results in increased expression of CDK4 mRNA] | CTD | PMID:11675954 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:621120 | 6480464 | Tretinoin results in decreased expression of CDK4 protein | CTD | PMID:11675954 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:621120 | 6480464 | Tretinoin inhibits the reaction [FGF2 protein results in increased expression of CDK4 mRNA] | CTD | PMID:11675954 |
| amlodipine | multiple interactions | EXP | | 6480464 | Amlodipine results in decreased activity of and results in decreased expression of CDK4 protein | CTD | PMID:17217918 |
| ammonium chloride | affects expression | ISO | | 6480464 | Ammonium Chloride affects the expression of CDK4 mRNA; more ... | CTD | PMID:16483693 |
| ammonium chloride | increases expression | ISO | RGD:621120 | 6480464 | Ammonium Chloride results in increased expression of CDK4 mRNA | CTD | PMID:12420312 |
| ammonium chloride | affects expression | ISO | RGD:621120 | 6480464 | Ammonium Chloride affects the expression of CDK4 mRNA; more ... | CTD | PMID:16483693 |
| ammonium chloride | increases expression | ISO | | 6480464 | Ammonium Chloride results in increased expression of CDK4 mRNA | CTD | PMID:12420312 |
| andrographolide | multiple interactions | EXP | | 6480464 | andrographolide inhibits the reaction [CCND1 protein binds to CDK4 protein] | CTD | PMID:18619950 |
| andrographolide | decreases expression | EXP | | 6480464 | andrographolide results in decreased expression of CDK4 protein | CTD | PMID:18619950 |
| aniline | increases expression | ISO | | 6480464 | aniline results in increased expression of CDK4 protein | CTD | PMID:21070798 |
| aniline | increases expression | ISO | RGD:621120 | 6480464 | aniline results in increased expression of CDK4 protein | CTD | PMID:21070798 |
| arsenic atom | increases expression | EXP | | 6480464 | Arsenic results in increased expression of CDK4 mRNA | CTD | PMID:20654705 |
| baicalein | increases expression | EXP | | 6480464 | baicalein results in increased expression of CDK4 protein | CTD | PMID:22820424 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CDK4 mRNA | CTD | PMID:19027820 |
| benzo[a]pyrene | decreases expression | ISO | | 6480464 | Benzo(a)pyrene results in decreased expression of CDK4 mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | decreases expression | ISO | RGD:732062 | 6480464 | Benzo(a)pyrene results in decreased expression of CDK4 mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | CDK4 protein promotes the reaction [Benzo(a)pyrene results in increased expression of E2F1 protein] | CTD | PMID:16406622 |
| berberine | decreases expression | EXP | | 6480464 | Berberine results in decreased expression of CDK4 protein | CTD | PMID:16505103 |
| bezafibrate | increases expression | ISO | | 6480464 | Bezafibrate results in increased expression of CDK4 mRNA | CTD | PMID:15447978 |
| bezafibrate | increases expression | ISO | RGD:732062 | 6480464 | Bezafibrate results in increased expression of CDK4 mRNA | CTD | PMID:15447978 |
| bis(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:732062 | 6480464 | Diethylhexyl Phthalate results in decreased expression of CDK4 mRNA | CTD | PMID:19874833 |
| bis(2-ethylhexyl) phthalate | multiple interactions | ISO | | 6480464 | Estradiol inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of CDK4 mRNA] | CTD | PMID:19874833 |
| bis(2-ethylhexyl) phthalate | decreases expression | ISO | | 6480464 | Diethylhexyl Phthalate results in decreased expression of CDK4 mRNA | CTD | PMID:19874833 |
| bis(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:732062 | 6480464 | Estradiol inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of CDK4 mRNA] | CTD | PMID:19874833 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CDK4 mRNA | CTD | PMID:21826169 |
| bisphenol A | multiple interactions | EXP | | 6480464 | fulvestrant inhibits the reaction [bisphenol A results in increased expression of CDK4 protein] | CTD | PMID:19361625 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CDK4 protein | CTD | PMID:19361625 PMID:21277958 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CDK4 protein | CTD | PMID:21277958 |
| brassinolide | decreases expression | EXP | | 6480464 | brassinolide results in decreased expression of CDK4 protein | CTD | PMID:20833159 |
| busulfan | decreases expression | ISO | RGD:732062 | 6480464 | Busulfan results in decreased expression of CDK4 mRNA | CTD | PMID:15388331 |
| busulfan | decreases expression | ISO | | 6480464 | Busulfan results in decreased expression of CDK4 mRNA | CTD | PMID:15388331 |
| butyric acid | decreases expression | ISO | | 6480464 | Butyric Acid results in decreased expression of CDK4 mRNA | CTD | PMID:12800193 |
| butyric acid | decreases expression | ISO | RGD:621120 | 6480464 | Butyric Acid results in decreased expression of CDK4 mRNA | CTD | PMID:12800193 |
| cadmium dichloride | multiple interactions | ISO | RGD:732062 | 6480464 | [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of CDK4 protein | CTD | PMID:12135628 |
| cadmium dichloride | multiple interactions | ISO | | 6480464 | [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of CDK4 protein | CTD | PMID:12135628 |
| cadmium dichloride | decreases expression | ISO | RGD:621120 | 6480464 | Cadmium Chloride results in decreased expression of CDK4 mRNA | CTD | PMID:18636176 |
| cadmium dichloride | decreases expression | ISO | | 6480464 | Cadmium Chloride results in decreased expression of CDK4 mRNA | CTD | PMID:18636176 |
| caffeine | multiple interactions | ISO | RGD:732062 | 6480464 | Caffeine results in decreased activity of [CCND1 protein binds to CDK4 protein] | CTD | PMID:15126379 |
| caffeine | multiple interactions | ISO | | 6480464 | Caffeine results in decreased activity of [CCND1 protein binds to CDK4 protein] | CTD | PMID:15126379 |
| caffeine | decreases expression | EXP | | 6480464 | Caffeine results in decreased expression of CDK4 mRNA | CTD | PMID:11793227 |
| calcitriol | multiple interactions | EXP | | 6480464 | Calcitriol promotes the reaction [CDKN1B protein binds to CDK4 protein] | CTD | PMID:16322758 |
| capsaicin | decreases expression | ISO | | 6480464 | Capsaicin results in decreased expression of CDK4 mRNA | CTD | PMID:16278290 |
| capsaicin | decreases expression | ISO | RGD:621120 | 6480464 | Capsaicin results in decreased expression of CDK4 mRNA | CTD | PMID:16278290 |
| celecoxib | decreases expression | EXP | | 6480464 | celecoxib results in decreased expression of CDK4 protein | CTD | PMID:16136956 |
| chromium(6+) | decreases expression | ISO | | 6480464 | chromium hexavalent ion results in decreased expression of CDK4 protein | CTD | PMID:21621607 |
| chromium(6+) | decreases expression | ISO | RGD:621120 | 6480464 | chromium hexavalent ion results in decreased expression of CDK4 protein | CTD | PMID:21621607 |
| chromium(6+) | multiple interactions | ISO | RGD:621120 | 6480464 | Ascorbic Acid inhibits the reaction [chromium hexavalent ion results in decreased expression of CDK4 protein] | CTD | PMID:21621607 |
| chromium(6+) | multiple interactions | ISO | | 6480464 | Ascorbic Acid inhibits the reaction [chromium hexavalent ion results in decreased expression of CDK4 protein] | CTD | PMID:21621607 |
| ciglitazone | multiple interactions | EXP | | 6480464 | CREBBP protein inhibits the reaction [ciglitazone results in decreased expression of CDK4 protein]; more ... | CTD | PMID:21080969 |
| ciglitazone | decreases expression | EXP | | 6480464 | ciglitazone results in decreased expression of CDK4 protein | CTD | PMID:21080969 |
| cisplatin | multiple interactions | EXP | | 6480464 | Cisplatin results in decreased activity of [CCND1 protein binds to CDK4 protein] | CTD | PMID:21592546 |
| cisplatin | decreases expression | ISO | | 6480464 | Cisplatin results in decreased expression of CDK4 mRNA | CTD | PMID:21151649 |
| cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of CDK4 protein | CTD | PMID:20195699 |
| cisplatin | multiple interactions | EXP | | 6480464 | (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane inhibits the reaction [Cisplatin results in decreased expression of CDK4 protein]; more ... | CTD | PMID:20195699 |
| cisplatin | decreases expression | ISO | RGD:732062 | 6480464 | Cisplatin results in decreased expression of CDK4 mRNA | CTD | PMID:21151649 |
| clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of CDK4 protein | CTD | PMID:21080969 |
| clofibrate | multiple interactions | EXP | | 6480464 | CREBBP protein inhibits the reaction [Clofibrate results in decreased expression of CDK4 protein]; more ... | CTD | PMID:21080969 |
| clofibric acid | multiple interactions | ISO | RGD:621120 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CDK4 mRNA | CTD | PMID:17602206 |
| clofibric acid | multiple interactions | ISO | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CDK4 mRNA | CTD | PMID:17602206 |
| clotrimazole | decreases expression | EXP | | 6480464 | Clotrimazole results in decreased expression of CDK4 | CTD | PMID:20724915 |
| clozapine | increases expression | ISO | RGD:621120 | 6480464 | Clozapine results in increased expression of CDK4 mRNA | CTD | PMID:15860345 |
| clozapine | increases expression | ISO | | 6480464 | Clozapine results in increased expression of CDK4 mRNA | CTD | PMID:15860345 |
| cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of CDK4 mRNA | CTD | PMID:19376846 |
| cocaine | affects expression | ISO | RGD:732062 | 6480464 | Cocaine affects the expression of CDK4 mRNA | CTD | PMID:18355967 |
| cocaine | affects expression | ISO | | 6480464 | Cocaine affects the expression of CDK4 mRNA | CTD | PMID:18355967 |
| corticosterone | multiple interactions | ISO | RGD:621120 | 6480464 | Corticosterone inhibits the reaction [CDKN1A protein binds to CDK4 protein]; more ... | CTD | PMID:12807724 |
| corticosterone | decreases activity | ISO | | 6480464 | Corticosterone results in decreased activity of CDK4 protein | CTD | PMID:12807724 |
| corticosterone | decreases expression | ISO | | 6480464 | Corticosterone results in decreased expression of CDK4 protein | CTD | PMID:12807724 |
| corticosterone | multiple interactions | ISO | | 6480464 | Corticosterone inhibits the reaction [CDKN1A protein binds to CDK4 protein]; more ... | CTD | PMID:12807724 |
| corticosterone | decreases expression | ISO | RGD:621120 | 6480464 | Corticosterone results in decreased expression of CDK4 protein | CTD | PMID:12807724 |
| corticosterone | decreases activity | ISO | RGD:621120 | 6480464 | Corticosterone results in decreased activity of CDK4 protein | CTD | PMID:12807724 |
| curcumin | decreases expression | EXP | | 6480464 | Curcumin results in decreased expression of CDK4 protein | CTD | PMID:18156803 |
| cyclosporin A | decreases expression | ISO | | 6480464 | Cyclosporine results in decreased expression of CDK4 mRNA | CTD | PMID:19770486 |
| cyclosporin A | decreases expression | ISO | RGD:732062 | 6480464 | Cyclosporine results in decreased expression of CDK4 mRNA | CTD | PMID:19770486 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of CDK4 mRNA | CTD | PMID:20106945 |
| daidzein | decreases activity | EXP | | 6480464 | daidzein results in decreased activity of CDK4 protein | CTD | PMID:21161820 |
| dasatinib (anhydrous) | multiple interactions | EXP | | 6480464 | [NVP-AEW541 co-treated with dasatinib] results in decreased expression of CDK4 protein | CTD | PMID:20664932 |
| dexamethasone | decreases expression | ISO | RGD:732062 | 6480464 | Dexamethasone results in decreased expression of CDK4 mRNA | CTD | PMID:21041162 |
| dexamethasone | decreases expression | ISO | | 6480464 | Dexamethasone results in decreased expression of CDK4 mRNA | CTD | PMID:21041162 |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of CDK4 mRNA | CTD | PMID:17530438 more ... |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of CDK4 mRNA | CTD | PMID:17530438 more ... |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of CDK4 mRNA | CTD | PMID:20016248 more ... |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of CDK4 mRNA | CTD | PMID:19769630 more ... |
| dibutyl phthalate | decreases expression | ISO | | 6480464 | Dibutyl Phthalate results in decreased expression of CDK4 mRNA | CTD | PMID:17361019 PMID:21266533 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of CDK4 mRNA | CTD | PMID:22179484 |
| dibutyl phthalate | decreases expression | ISO | RGD:732062 | 6480464 | Dibutyl Phthalate results in decreased expression of CDK4 mRNA | CTD | PMID:17361019 PMID:21266533 |
| dibutyl phthalate | decreases expression | ISO | RGD:732062 | 6480464 | Dibutyl Phthalate results in decreased expression of CDK4 mRNA | CTD | PMID:21266533 |
| dichlorine | multiple interactions | ISO | RGD:621120 | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of CDK4 mRNA | CTD | PMID:18636392 |
| dichlorine | multiple interactions | ISO | | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of CDK4 mRNA | CTD | PMID:18636392 |
| diethylstilbestrol | increases expression | ISO | RGD:621120 | 6480464 | Diethylstilbestrol results in increased expression of CDK4 mRNA | CTD | PMID:15890375 |
| diethylstilbestrol | decreases expression | ISO | | 6480464 | Diethylstilbestrol results in decreased expression of CDK4 mRNA | CTD | PMID:21041162 |
| diethylstilbestrol | decreases expression | ISO | RGD:732062 | 6480464 | Diethylstilbestrol results in decreased expression of CDK4 mRNA | CTD | PMID:21041162 |
| diethylstilbestrol | increases expression | ISO | | 6480464 | Diethylstilbestrol results in increased expression of CDK4 mRNA | CTD | PMID:15890375 |
| disodium selenite | increases expression | EXP | | 6480464 | Sodium Selenite results in increased expression of CDK4 mRNA | CTD | PMID:16705456 |
| doxorubicin | multiple interactions | ISO | RGD:732062 | 6480464 | Doxorubicin promotes the reaction [AZD 6244 results in decreased expression of CDK4 protein] | CTD | PMID:17876044 |
| doxorubicin | multiple interactions | ISO | | 6480464 | [zoledronic acid co-treated with Doxorubicin] results in decreased expression of CDK4 protein | CTD | PMID:19789217 |
| doxorubicin | multiple interactions | ISO | | 6480464 | Doxorubicin promotes the reaction [AZD 6244 results in decreased expression of CDK4 protein] | CTD | PMID:17876044 |
| doxorubicin | multiple interactions | ISO | RGD:732062 | 6480464 | [zoledronic acid co-treated with Doxorubicin] results in decreased expression of CDK4 protein | CTD | PMID:19789217 |
| elemental selenium | decreases expression | EXP | | 6480464 | Selenium deficiency results in decreased expression of CDK4 mRNA | CTD | PMID:11925459 |
| elemental selenium | increases expression | EXP | | 6480464 | Selenium results in increased expression of CDK4 mRNA | CTD | PMID:19244175 |
| emodin | decreases expression | EXP | | 6480464 | Emodin results in decreased expression of CDK4 mRNA | CTD | PMID:16045814 |
| esculetin | multiple interactions | ISO | | 6480464 | SB 203580 inhibits the reaction [esculetin results in decreased expression of CDK4 protein]; more ... | CTD | PMID:21600278 |
| esculetin | multiple interactions | ISO | RGD:621120 | 6480464 | esculetin promotes the reaction [CDKN1A protein binds to CDK4 protein]; more ... | CTD | PMID:21600278 |
| esculetin | decreases expression | ISO | RGD:621120 | 6480464 | esculetin results in decreased expression of CDK4 protein | CTD | PMID:21600278 |
| esculetin | decreases expression | ISO | | 6480464 | esculetin results in decreased expression of CDK4 protein | CTD | PMID:21600278 |
| fulvestrant | multiple interactions | EXP | | 6480464 | fulvestrant inhibits the reaction [bisphenol A results in increased expression of CDK4 protein]; more ... | CTD | PMID:19361625 |
| furan | increases methylation | ISO | | 6480464 | furan results in increased methylation of CDK4 gene | CTD | PMID:22079235 |
| furan | increases methylation | ISO | RGD:621120 | 6480464 | furan results in increased methylation of CDK4 gene | CTD | PMID:22079235 |
| genistein | decreases activity | EXP | | 6480464 | Genistein results in decreased activity of CDK4 protein | CTD | PMID:21161820 |
| glutathione | increases expression | ISO | | 6480464 | Glutathione deficiency results in increased expression of CDK4 mRNA | CTD | PMID:15345336 |
| glutathione | increases expression | ISO | RGD:621120 | 6480464 | Glutathione deficiency results in increased expression of CDK4 mRNA | CTD | PMID:15345336 |
| haloperidol | increases expression | ISO | | 6480464 | Haloperidol results in increased expression of CDK4 mRNA | CTD | PMID:15860345 |
| haloperidol | increases expression | ISO | RGD:621120 | 6480464 | Haloperidol results in increased expression of CDK4 mRNA | CTD | PMID:15860345 |
| hesperetin | multiple interactions | EXP | | 6480464 | hesperetin promotes the reaction [CDK4 protein binds to CDKN1A protein] | CTD | PMID:17927510 |
| hesperetin | decreases expression | EXP | | 6480464 | hesperetin results in decreased expression of CDK4 | CTD | PMID:17927510 |
| hydralazine | multiple interactions | EXP | | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of CDK4 mRNA | CTD | PMID:17183730 |
| hydroxyurea | decreases expression | ISO | | 6480464 | Hydroxyurea results in decreased expression of CDK4 protein | CTD | PMID:16356682 |
| hydroxyurea | decreases expression | ISO | RGD:732062 | 6480464 | Hydroxyurea results in decreased expression of CDK4 protein | CTD | PMID:16356682 |
| imatinib | decreases expression | EXP | | 6480464 | imatinib results in decreased expression of CDK4 mRNA | CTD | PMID:19208803 |
| imatinib | multiple interactions | EXP | | 6480464 | [imatinib co-treated with tetraarsenic tetrasulfide] results in decreased expression of CDK4 mRNA | CTD | PMID:19208803 |
| indole-3-methanol | increases expression | EXP | | 6480464 | indole-3-carbinol analog results in increased expression of CDK4 protein | CTD | PMID:20570586 |
| indole-3-methanol | decreases expression | EXP | | 6480464 | indole-3-carbinol results in decreased expression of CDK4 | CTD | PMID:16082211 |
| indole-3-methanol | decreases activity | EXP | | 6480464 | indole-3-carbinol analog results in decreased activity of CDK4 protein | CTD | PMID:20570586 |
| indolin-2-one | decreases activity | EXP | | 6480464 | 2-oxindole results in decreased activity of CDK4 protein | CTD | PMID:15724842 |
| indomethacin | decreases expression | EXP | | 6480464 | Indomethacin results in decreased expression of CDK4 protein | CTD | PMID:15786552 |
| L-ascorbic acid | multiple interactions | ISO | | 6480464 | Ascorbic Acid inhibits the reaction [chromium hexavalent ion results in decreased expression of CDK4 protein] | CTD | PMID:21621607 |
| L-ascorbic acid | multiple interactions | ISO | RGD:621120 | 6480464 | Ascorbic Acid inhibits the reaction [chromium hexavalent ion results in decreased expression of CDK4 protein] | CTD | PMID:21621607 |
| lead(0) | increases expression | EXP | | 6480464 | Lead results in increased expression of CDK4 mRNA | CTD | PMID:19921347 |
| lidocaine | affects expression | ISO | RGD:732062 | 6480464 | Lidocaine affects the expression of CDK4 mRNA | CTD | PMID:18931217 |
| lidocaine | affects expression | ISO | | 6480464 | Lidocaine affects the expression of CDK4 mRNA | CTD | PMID:18931217 |
| lycopene | decreases expression | EXP | | 6480464 | lycopene results in decreased expression of CDK4 protein | CTD | PMID:17337101 |
| malachite green cation | multiple interactions | ISO | | 6480464 | [Diethylnitrosamine co-treated with malachite green] results in increased expression of CDK4 protein; more ... | CTD | PMID:12616621 |
| malachite green cation | multiple interactions | ISO | RGD:621120 | 6480464 | [Diethylnitrosamine co-treated with malachite green] results in increased expression of CDK4 mRNA; more ... | CTD | PMID:12616621 |
| melatonin | decreases expression | EXP | | 6480464 | Melatonin results in decreased expression of CDK4 protein; more ... | CTD | PMID:21108658 |
| menadione | decreases expression | EXP | | 6480464 | Vitamin K 3 results in decreased expression of CDK4 mRNA | CTD | PMID:16010434 |
| menaquinone | decreases expression | EXP | | 6480464 | Vitamin K 2 results in decreased expression of CDK4 mRNA | CTD | PMID:16010434 |
| methapyrilene | increases expression | ISO | | 6480464 | Methapyrilene results in increased expression of CDK4 mRNA | CTD | PMID:15890375 |
| methapyrilene | increases expression | ISO | RGD:621120 | 6480464 | Methapyrilene results in increased expression of CDK4 mRNA | CTD | PMID:15890375 |
| methoxychlor | increases expression | ISO | | 6480464 | Methoxychlor metabolite results in increased expression of CDK4 protein; more ... | CTD | PMID:15525693 |
| methoxychlor | multiple interactions | ISO | | 6480464 | Acetylcysteine inhibits the reaction [Methoxychlor results in decreased expression of CDK4 mRNA] | CTD | PMID:19615393 |
| methoxychlor | decreases expression | ISO | | 6480464 | Methoxychlor results in decreased expression of CDK4 protein; more ... | CTD | PMID:19615393 |
| methoxychlor | decreases expression | ISO | RGD:732062 | 6480464 | Methoxychlor results in decreased expression of CDK4 protein; more ... | CTD | PMID:19615393 |
| methoxychlor | multiple interactions | ISO | RGD:732062 | 6480464 | Acetylcysteine inhibits the reaction [Methoxychlor results in decreased expression of CDK4 mRNA] | CTD | PMID:19615393 |
| methoxychlor | increases expression | ISO | RGD:732062 | 6480464 | Methoxychlor metabolite results in increased expression of CDK4 protein; more ... | CTD | PMID:15525693 |
| mono(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:732062 | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of CDK4 mRNA | CTD | PMID:19874833 |
| mono(2-ethylhexyl) phthalate | decreases expression | ISO | | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of CDK4 mRNA | CTD | PMID:19874833 |
| mono(2-ethylhexyl) phthalate | multiple interactions | ISO | | 6480464 | Estradiol inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of CDK4 mRNA] | CTD | PMID:19874833 |
| mono(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:732062 | 6480464 | Estradiol inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of CDK4 mRNA] | CTD | PMID:19874833 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:732062 | 6480464 | Acetylcysteine inhibits the reaction [Methoxychlor results in decreased expression of CDK4 mRNA] | CTD | PMID:19615393 |
| N-acetyl-L-cysteine | multiple interactions | ISO | | 6480464 | Acetylcysteine inhibits the reaction [Methoxychlor results in decreased expression of CDK4 mRNA] | CTD | PMID:19615393 |
| N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | ISO | RGD:732062 | 6480464 | [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of CDK4 protein | CTD | PMID:12135628 |
| N-methyl-N'-nitro-N-nitrosoguanidine | increases expression | ISO | RGD:621120 | 6480464 | Methylnitronitrosoguanidine results in increased expression of CDK4 protein | CTD | PMID:21628965 |
| N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | ISO | | 6480464 | [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of CDK4 protein | CTD | PMID:12135628 |
| N-methyl-N'-nitro-N-nitrosoguanidine | increases expression | ISO | | 6480464 | Methylnitronitrosoguanidine results in increased expression of CDK4 protein | CTD | PMID:21628965 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:621120 | 6480464 | [Diethylnitrosamine co-treated with malachite green] results in increased expression of CDK4 protein; more ... | CTD | PMID:12616621 |
| N-nitrosodiethylamine | increases expression | ISO | | 6480464 | Diethylnitrosamine results in increased expression of CDK4 protein | CTD | PMID:19822196 PMID:11831363 |
| N-nitrosodiethylamine | increases expression | ISO | | 6480464 | Diethylnitrosamine results in increased expression of CDK4 protein | CTD | PMID:11831363 PMID:19822196 |
| N-nitrosodiethylamine | multiple interactions | ISO | | 6480464 | [Diethylnitrosamine co-treated with malachite green] results in increased expression of CDK4 mRNA; more ... | CTD | PMID:12616621 |
| N-nitrosodiethylamine | multiple interactions | ISO | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CDK4 mRNA | CTD | PMID:17602206 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:621120 | 6480464 | Diethylnitrosamine results in increased expression of CDK4 protein | CTD | PMID:19822196 PMID:11831363 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:621120 | 6480464 | Diethylnitrosamine results in increased expression of CDK4 protein | CTD | PMID:11831363 PMID:19822196 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:621120 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CDK4 mRNA | CTD | PMID:17602206 |
| N-nitrosodimethylamine | increases expression | ISO | | 6480464 | Dimethylnitrosamine results in increased expression of CDK4 mRNA | CTD | PMID:15890375 |
| N-nitrosodimethylamine | increases expression | ISO | RGD:621120 | 6480464 | Dimethylnitrosamine results in increased expression of CDK4 mRNA | CTD | PMID:15890375 |
| ozone | multiple interactions | ISO | | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of CDK4 mRNA | CTD | PMID:18636392 |
| ozone | multiple interactions | ISO | RGD:621120 | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of CDK4 mRNA | CTD | PMID:18636392 |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of CDK4 mRNA | CTD | PMID:11793227 |
| paracetamol | affects expression | ISO | | 6480464 | Acetaminophen affects the expression of CDK4 mRNA | CTD | PMID:17562736 |
| paracetamol | affects expression | ISO | RGD:732062 | 6480464 | Acetaminophen affects the expression of CDK4 mRNA | CTD | PMID:17562736 |
| pentachlorophenol | increases expression | ISO | | 6480464 | Pentachlorophenol results in increased expression of CDK4 mRNA; more ... | CTD | PMID:19442831 |
| pentachlorophenol | increases expression | ISO | RGD:621120 | 6480464 | Pentachlorophenol results in increased expression of CDK4 mRNA; more ... | CTD | PMID:19442831 |
| phenobarbital | affects expression | ISO | RGD:732062 | 6480464 | Phenobarbital affects the expression of CDK4 mRNA | CTD | PMID:23091169 |
| phenylephrine | increases expression | ISO | | 6480464 | Phenylephrine results in increased expression of CDK4 protein | CTD | PMID:15603588 |
| phenylephrine | increases expression | ISO | RGD:621120 | 6480464 | Phenylephrine results in increased expression of CDK4 protein | CTD | PMID:15603588 |
| phorbol 13-acetate 12-myristate | decreases expression | EXP | | 6480464 | Tetradecanoylphorbol Acetate results in decreased expression of CDK4 mRNA | CTD | PMID:15978937 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of CDK4 mRNA | CTD | PMID:10866668 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | | 6480464 | PPARD protein affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of CDK4 mRNA] | CTD | PMID:10866668 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:732062 | 6480464 | PPARD protein affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of CDK4 mRNA] | CTD | PMID:10866668 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:732062 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of CDK4 mRNA | CTD | PMID:10866668 |
| piperonyl butoxide | increases expression | ISO | | 6480464 | Piperonyl Butoxide results in increased expression of CDK4 mRNA | CTD | PMID:15890375 |
| piperonyl butoxide | increases expression | ISO | RGD:621120 | 6480464 | Piperonyl Butoxide results in increased expression of CDK4 mRNA | CTD | PMID:15890375 |
| pirinixic acid | increases expression | ISO | | 6480464 | pirinixic acid results in increased expression of CDK4 mRNA | CTD | PMID:15890375 |
| pirinixic acid | increases expression | ISO | | 6480464 | pirinixic acid results in increased expression of CDK4 mRNA | CTD | PMID:16377806 PMID:18301758 |
| pirinixic acid | decreases expression | ISO | | 6480464 | pirinixic acid results in decreased expression of CDK4 mRNA | CTD | PMID:18445702 |
| pirinixic acid | multiple interactions | ISO | | 6480464 | PPARA protein affects the reaction [pirinixic acid results in increased expression of CDK4 protein] | CTD | PMID:17483499 |
| pirinixic acid | increases expression | ISO | | 6480464 | pirinixic acid results in increased expression of CDK4 protein | CTD | PMID:17483499 |
| pirinixic acid | increases expression | ISO | RGD:732062 | 6480464 | pirinixic acid results in increased expression of CDK4 protein | CTD | PMID:17483499 |
| pirinixic acid | multiple interactions | ISO | RGD:732062 | 6480464 | PPARA protein affects the reaction [pirinixic acid results in increased expression of CDK4 protein] | CTD | PMID:17483499 |
| pirinixic acid | increases expression | ISO | RGD:732062 | 6480464 | pirinixic acid results in increased expression of CDK4 mRNA | CTD | PMID:16377806 PMID:18301758 |
| pirinixic acid | increases expression | ISO | RGD:621120 | 6480464 | pirinixic acid results in increased expression of CDK4 mRNA | CTD | PMID:15890375 |
| pirinixic acid | increases expression | ISO | RGD:732062 | 6480464 | pirinixic acid results in increased expression of CDK4 mRNA | CTD | PMID:18301758 PMID:16377806 |
| pirinixic acid | decreases expression | ISO | RGD:732062 | 6480464 | pirinixic acid results in decreased expression of CDK4 mRNA | CTD | PMID:18445702 |
| pterostilbene | decreases expression | ISO | | 6480464 | pterostilbene results in decreased expression of CDK4 protein | CTD | PMID:20398797 |
| pterostilbene | decreases expression | ISO | RGD:621120 | 6480464 | pterostilbene results in decreased expression of CDK4 protein | CTD | PMID:20398797 |
| pyrogallol | multiple interactions | ISO | RGD:732062 | 6480464 | Silymarin inhibits the reaction [Pyrogallol results in decreased expression of CDK4 mRNA] | CTD | PMID:20362636 |
| pyrogallol | multiple interactions | ISO | | 6480464 | Silymarin inhibits the reaction [Pyrogallol results in decreased expression of CDK4 mRNA] | CTD | PMID:20362636 |
| pyrogallol | decreases expression | ISO | | 6480464 | Pyrogallol results in decreased expression of CDK4 mRNA | CTD | PMID:20362636 |
| pyrogallol | decreases expression | ISO | RGD:732062 | 6480464 | Pyrogallol results in decreased expression of CDK4 mRNA | CTD | PMID:20362636 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [TNF protein results in increased activity of CDK4 protein]; more ... | CTD | PMID:12589822 |
| quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of CDK4 mRNA | CTD | PMID:14715546 PMID:15309432 |
| quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of CDK4 mRNA | CTD | PMID:15309432 PMID:14715546 |
| resveratrol | decreases expression | ISO | RGD:732062 | 6480464 | resveratrol results in decreased expression of CDK4 protein | CTD | PMID:15122319 |
| resveratrol | decreases expression | ISO | | 6480464 | resveratrol results in decreased expression of CDK4 protein | CTD | PMID:15122319 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol results in decreased expression of [CCND1 protein binds to CDK4 protein] | CTD | PMID:11481417 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of CDK4 protein | CTD | PMID:17050787 more ... |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of CDK4 protein | CTD | PMID:11481417 more ... |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of CDK4 protein | CTD | PMID:17804756 PMID:17050787 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of CDK4 mRNA | CTD | PMID:12569576 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of CDK4 protein | CTD | PMID:17050787 PMID:17804756 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol results in decreased activity of [CCND1 protein binds to CDK4 protein] | CTD | PMID:17050787 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [TNF protein results in increased expression of and results in increased activity of CDK4 protein]; more ... | CTD | PMID:16317118 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol affects the activity of [CCND1 protein co-treated with CDK4 protein] | CTD | PMID:12392819 |
| resveratrol | affects expression | EXP | | 6480464 | resveratrol affects the expression of CDK4 protein | CTD | PMID:12392819 |
| rosiglitazone | decreases expression | EXP | | 6480464 | rosiglitazone results in decreased expression of CDK4 protein | CTD | PMID:20210794 |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of CDK4 mRNA | CTD | PMID:17639046 |
| S-(1,2-dichlorovinyl)-L-cysteine | increases expression | ISO | RGD:732062 | 6480464 | S-(1,2-dichlorovinyl)cysteine results in increased expression of CDK4 protein | CTD | PMID:16495211 |
| S-(1,2-dichlorovinyl)-L-cysteine | increases expression | ISO | | 6480464 | S-(1,2-dichlorovinyl)cysteine results in increased expression of CDK4 protein | CTD | PMID:16495211 |
| selenium atom | decreases expression | EXP | | 6480464 | Selenium deficiency results in decreased expression of CDK4 mRNA | CTD | PMID:11925459 |
| selenium atom | increases expression | EXP | | 6480464 | Selenium results in increased expression of CDK4 mRNA | CTD | PMID:19244175 |
| simvastatin | decreases activity | ISO | | 6480464 | Simvastatin results in decreased activity of CDK4 protein | CTD | PMID:18804536 |
| simvastatin | decreases activity | ISO | RGD:621120 | 6480464 | Simvastatin results in decreased activity of CDK4 protein | CTD | PMID:18804536 |
| simvastatin | decreases expression | EXP | | 6480464 | Simvastatin results in decreased expression of CDK4 protein | CTD | PMID:20878096 |
| sodium dichromate | increases expression | ISO | | 6480464 | sodium bichromate results in increased expression of CDK4 mRNA | CTD | PMID:22561333 |
| sodium dichromate | increases expression | ISO | RGD:621120 | 6480464 | sodium bichromate results in increased expression of CDK4 mRNA | CTD | PMID:22561333 |
| sulindac | multiple interactions | EXP | | 6480464 | CTNNB1 protein affects the reaction [Sulindac results in decreased expression of CDK4 protein] | CTD | PMID:18291362 |
| sulindac | multiple interactions | ISO | RGD:621120 | 6480464 | [Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of CDK4 mRNA | CTD | PMID:20371263 |
| sulindac | multiple interactions | ISO | | 6480464 | [Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of CDK4 mRNA | CTD | PMID:20371263 |
| sulindac | decreases expression | EXP | | 6480464 | Sulindac results in decreased expression of CDK4 protein | CTD | PMID:17292881 PMID:18291362 |
| sulindac | decreases expression | EXP | | 6480464 | Sulindac results in decreased expression of CDK4 protein | CTD | PMID:18291362 PMID:17292881 |
| terephthalic acid | increases expression | ISO | | 6480464 | terephthalic acid results in increased expression of CDK4 protein | CTD | PMID:16896691 |
| terephthalic acid | increases expression | ISO | RGD:621120 | 6480464 | terephthalic acid results in increased expression of CDK4 protein | CTD | PMID:16896691 |
| tetrachloromethane | increases expression | ISO | RGD:621120 | 6480464 | Carbon Tetrachloride results in increased expression of CDK4 protein | CTD | PMID:17298859 |
| tetrachloromethane | increases expression | ISO | | 6480464 | Carbon Tetrachloride results in increased expression of CDK4 protein | CTD | PMID:17298859 |
| thimerosal | decreases expression | EXP | | 6480464 | Thimerosal results in decreased expression of CDK4 protein | CTD | PMID:16649253 |
| thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of CDK4 mRNA | CTD | PMID:11793227 |
| thioridazine | decreases expression | EXP | | 6480464 | Thioridazine results in decreased expression of CDK4 protein | CTD | PMID:21035837 |
| tocopherol | multiple interactions | EXP | | 6480464 | Tocopherols results in decreased expression of and results in decreased activity of CDK4 protein | CTD | PMID:12504091 |
| trans-resveratrol | affects expression | EXP | | 6480464 | resveratrol affects the expression of CDK4 protein | CTD | PMID:12392819 |
| trans-resveratrol | decreases expression | ISO | | 6480464 | resveratrol results in decreased expression of CDK4 protein | CTD | PMID:15122319 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol results in decreased expression of [CCND1 protein binds to CDK4 protein] | CTD | PMID:11481417 |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of CDK4 protein | CTD | PMID:17050787 more ... |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of CDK4 protein | CTD | PMID:11481417 more ... |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of CDK4 protein | CTD | PMID:17804756 PMID:17050787 |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of CDK4 mRNA | CTD | PMID:12569576 |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of CDK4 protein | CTD | PMID:17050787 PMID:17804756 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol results in decreased activity of [CCND1 protein binds to CDK4 protein] | CTD | PMID:17050787 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [TNF protein results in increased expression of and results in increased activity of CDK4 protein]; more ... | CTD | PMID:16317118 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol affects the activity of [CCND1 protein co-treated with CDK4 protein] | CTD | PMID:12392819 |
| trans-resveratrol | decreases expression | ISO | RGD:732062 | 6480464 | resveratrol results in decreased expression of CDK4 protein | CTD | PMID:15122319 |
| trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of CDK4 mRNA | CTD | PMID:19606018 |
| trimellitic anhydride | increases expression | ISO | RGD:732062 | 6480464 | trimellitic anhydride results in increased expression of CDK4 mRNA | CTD | PMID:19042947 |
| trimellitic anhydride | increases expression | ISO | | 6480464 | trimellitic anhydride results in increased expression of CDK4 mRNA | CTD | PMID:19042947 |
| troglitazone | multiple interactions | EXP | | 6480464 | GSK3B protein affects the susceptibility to [troglitazone results in decreased expression of CDK4 protein]; more ... | CTD | PMID:20540935 |
| troglitazone | decreases expression | ISO | | 6480464 | troglitazone results in decreased expression of CDK4 protein | CTD | PMID:15610522 |
| troglitazone | decreases expression | ISO | RGD:732062 | 6480464 | troglitazone results in decreased expression of CDK4 protein | CTD | PMID:15610522 |
| troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of CDK4 mRNA | CTD | PMID:19140230 |
| troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of CDK4 protein | CTD | PMID:20540935 |
| tubocurarine | multiple interactions | EXP | | 6480464 | Tubocurarine inhibits the reaction [Nicotine results in decreased expression of CDK4 protein] | CTD | PMID:15231866 |
| urethane | increases expression | ISO | RGD:732062 | 6480464 | Urethane results in increased expression of CDK4 mRNA; more ... | CTD | PMID:12117781 |
| urethane | increases expression | ISO | | 6480464 | Urethane results in increased expression of CDK4 mRNA; more ... | CTD | PMID:12117781 |
| valproic acid | multiple interactions | EXP | | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of CDK4 mRNA | CTD | PMID:17183730 |
| vinyl carbamate | decreases expression | ISO | RGD:732062 | 6480464 | vinyl carbamate results in decreased expression of CDK4 mRNA | CTD | PMID:17849452 |
| vinyl carbamate | decreases expression | ISO | | 6480464 | vinyl carbamate results in decreased expression of CDK4 mRNA | CTD | PMID:17849452 |
| zidovudine | multiple interactions | EXP | | 6480464 | [Zidovudine co-treated with IFNA1 protein] results in increased expression of CDK4 mRNA | CTD | PMID:20370541 |
| zoledronic acid | multiple interactions | ISO | RGD:732062 | 6480464 | [zoledronic acid co-treated with Doxorubicin] results in decreased expression of CDK4 protein | CTD | PMID:19789217 |
| zoledronic acid | multiple interactions | ISO | | 6480464 | [zoledronic acid co-treated with Doxorubicin] results in decreased expression of CDK4 protein | CTD | PMID:19789217 |